Nifty Pharma Today: Index Ends 0.12% Higher at 25,596.65

Quick sector takeaways

• Nifty Pharma ended 0.12% higher at 25,596.65, up 30.75 points from its previous close of 25,565.90.
• The index recovered from an intraday low of 25,113.55 and finished below its day high of 25,656.20.
• Breadth was mixed: 9 stocks advanced while 11 declined, showing that the index’s gain came despite more stocks closing lower.
• Aurobindo Pharma, Zydus Lifesciences, Torrent Pharmaceuticals and Cipla were among the notable gainers, while JB Chemicals & Pharmaceuticals, Gland Pharma and Lupin were among the key decliners. Watch whether the index can remain above 25,596.65 next session.

Nifty Pharma today: a positive close amid mixed stock moves

Nifty Pharma today closed with a modest gain of 0.12% in the 22 October 2026 session, finishing at 25,596.65. The index added 30.75 points over the previous close of 25,565.90, making it the strongest performer among the tracked NSE sector indices for the day.

The session was not a one-way advance. Nifty Pharma opened at 25,367.05, slipped to 25,113.55 during the day and later climbed to 25,656.20. Its closing level was 59.55 points below the session high, while remaining 483.10 points above the low. This price action indicates a recovery from lower levels before the close, even as stock-level participation remained divided.

For a broader market-sector perspective, readers can follow the Univest Market View.

Price snapshot

The index opened 198.85 points below the prior close, then travelled through a 542.65-point intraday range from low to high. By the end of the session, it had moved back above the previous close. The close, recorded at 4:15 PM IST, left Nifty Pharma near the upper end of its day’s range.

Sector ranking

Nifty Pharma was the top gaining sector index on 22 October, although its 0.12% rise was measured rather than broad-based. The complete session ranking across the tracked indices, from strongest to weakest, was as follows:

1. Nifty Pharma: +0.12%.
2. Nifty Bank: -0.09%.
3. Nifty Financial Services: -0.14%.
4. Nifty Mid Select: -0.39%.
5. Nifty Metal: -0.52%.
6. Nifty Auto: -0.73%.
7. Nifty IT: -1.05%.
8. Nifty FMCG: -1.41%.

The ranking places pharma at the head of the group because it was the only index in this comparison to close in positive territory. Nifty Bank and Nifty Financial Services recorded comparatively contained declines, whereas FMCG, IT and Auto saw larger percentage falls.

Constituent breadth

The sector’s stocks presented a mixed closing picture. Of the 20 Nifty Pharma stocks, 9 advanced and 11 declined, with none unchanged. The advance-decline reading of 0.82 shows that gainers were fewer than decliners, despite the index ending higher.

This contrast is important: an index can rise while more individual stocks fall, depending on the relative price moves across its stocks. In this session, positive moves in select names coexisted with notable declines elsewhere in the sector.

Heavyweights versus broader participation

Among prominent Nifty Pharma names, Sun Pharmaceutical Industries gained 0.74% to Rs. 1,758.00 and finished at its day high. Torrent Pharmaceuticals rose 1.35% to Rs. 4,615.30, while Cipla advanced 1.29% to Rs. 1,330.90, also ending at its intraday high.

There was counterweight from other widely followed names. Divi’s Laboratories fell 0.30% to Rs. 9,162.00 and Dr. Reddy’s Laboratories declined 0.44% to Rs. 1,239.00. The mix reinforces the breadth reading: the index closed green, but participation was not uniform across larger pharma stocks.

Key Nifty Pharma stocks

Biggest positive movers

Aurobindo Pharma led the gainers with a 2.03% rise to Rs. 1,610.90, exactly matching its day high. Zydus Lifesciences followed with a 1.58% gain to Rs. 1,135.00. Torrent Pharmaceuticals gained 1.35%, Cipla rose 1.29% and Granules India added 1.16% to Rs. 817.00. These gains helped lift the index through a session where decliners remained in the majority.

Biggest negative movers

JB Chemicals & Pharmaceuticals fell 3.87% to Rs. 2,408.90 after trading between Rs. 2,380.00 and Rs. 2,525.50. Gland Pharma declined 2.88% to Rs. 2,850.40, while Lupin lost 2.14% to Rs. 1,922.00. Biocon slipped 1.40%, and Abbott India fell 1.25%. These declines explain why the positive index finish should be read alongside the softer breadth.

Stocks to watch next session

• Aurobindo Pharma, after closing at Rs. 1,610.90, its day high.
• Zydus Lifesciences, after a 1.58% rise to Rs. 1,135.00.
• Torrent Pharmaceuticals, following its 1.35% advance to Rs. 4,615.30.
• Cipla, which ended at Rs. 1,330.90, its intraday high.
• JB Chemicals & Pharmaceuticals, after a 3.87% fall to Rs. 2,408.90.
• Gland Pharma, after closing 2.88% lower at Rs. 2,850.40.

The constructive case

The constructive evidence is the positive close itself. Nifty Pharma rose 30.75 points, recovered substantially from its intraday low and ended only 59.55 points under the day high. Several notable gainers also closed at their session highs, including Aurobindo Pharma and Cipla. Sun Pharmaceutical Industries likewise ended at its day high after gaining 0.74%.

Relative performance was another favourable feature. Nifty Pharma was the only positive index in the complete sector comparison, while every other tracked index ended lower. That distinction puts the 0.12% gain in context, even though it was modest in absolute terms.

The cautious case

The cautious case rests on narrow participation. Eleven Nifty Pharma stocks declined against nine gainers, producing an advance-decline ratio below one. Sharp falls in JB Chemicals & Pharmaceuticals, Gland Pharma and Lupin sat alongside the gains in Aurobindo Pharma, Zydus Lifesciences, Torrent Pharmaceuticals and Cipla.

The closing level also remained below the day high after a wide intraday range. The next session will show whether the index can build on its recovery or whether the mixed breadth continues to limit follow-through.

Univest Insights

Nifty Pharma today offered relative strength at the sector-index level, finishing first in the day’s sector ranking. Its close above the previous close was achieved after an early lower opening and a dip to 25,113.55, highlighting a recovery during the session.

Stock selection within the sector remained important. Aurobindo Pharma’s 2.03% advance was the largest gain among the highlighted names, while Zydus Lifesciences, Torrent Pharmaceuticals and Cipla also closed higher. In contrast, the largest declines were concentrated in JB Chemicals & Pharmaceuticals, Gland Pharma and Lupin.

The mixed breadth means the positive index move should be assessed alongside individual price performance rather than as a uniform sector advance. The session combined a positive headline index result with more decliners than advancers.

In the next session, watch whether Nifty Pharma holds above 25,596.65 and whether the breadth improves from 9 advancers versus 11 decliners.

Published on 22 October 2026 at 4:15 PM IST

Frequently asked questions

What was Nifty Pharma’s closing level on 22 October 2026?

Nifty Pharma closed at 25,596.65, up 30.75 points or 0.12% from the previous close of 25,565.90.

What were the day high and day low for Nifty Pharma?

The index’s day high was 25,656.20 and its day low was 25,113.55.

Why was Nifty Pharma the top gaining sector index?

Nifty Pharma rose 0.12%, while every other tracked sector index closed lower in the session.

How was Nifty Pharma’s market breadth?

Nine stocks advanced and 11 declined, with no stocks unchanged.

Which stocks were the top gainers in Nifty Pharma?

Aurobindo Pharma, Zydus Lifesciences, Torrent Pharmaceuticals, Cipla and Granules India were the top gainers listed for the session.

Which stocks were the biggest decliners in Nifty Pharma?

JB Chemicals & Pharmaceuticals, Gland Pharma, Lupin, Biocon and Abbott India were the biggest decliners listed for the session.